Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report which finds that though the HIV drug market will grow to $15.1 billion by 2017, there will be fierce competition among drugmakers for market share.
Commercial Insight: HIV - The battle for market share is getting fiercer states that the HIV market, worth $9.3 billion in 2007, will be driven by the increasing prevalence of HIV worldwide and longer life expectancy of patients receiving treatment.
